Disposition of 6063 shares by Kevin Thornal of Nevro Corp at 4.85 subject to Rule 16b-3
| HO1 Stock | EUR 69.00 0.50 0.73% |
Roughly 52% of Hologic's investor base is interested to short. The analysis of current outlook of investing in Hologic suggests that many traders are impartial regarding Hologic's prospects. The current market sentiment, together with Hologic's historical and current headlines, can help investors time the market. In addition, many technical investors use Hologic stock news signals to limit their universe of possible portfolio assets.
Hologic stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Hologic daily returns and investor perception about the current price of Hologic as well as its diversification or hedging effects on your existing portfolios.
Hologic |
Filed transaction by Nevro Corp Director, Officer: President & Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Hologic Fundamental Analysis
We analyze Hologic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hologic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hologic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Hologic is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Hologic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hologic stock to make a market-neutral strategy. Peer analysis of Hologic could also be used in its relative valuation, which is a method of valuing Hologic by comparing valuation metrics with similar companies.
Peers
Hologic Related Equities
| RMEA | Resmed | 2.80 | ||||
| SRT3 | Sartorius Aktiengesellscha | 0.88 | ||||
| SRT4 | SARTORIUS | 0.59 | ||||
| RME | ResMed | 0.09 | ||||
| 56S1 | Sartorius Stedim | 0.00 | ||||
| IUI1 | Intuitive Surgical | 0.12 |
Complementary Tools for Hologic Stock analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |